Phase 1 Study of AMG 509 in Subjects With Metastatic Castration-Resistant Prostate Cancer

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504361-23-00

Acronym

20180146

Enrollment

Registered

2024-05-31

Start date

2023-03-30

Completion date

Unknown

Last updated

2025-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

None listed

Sex/Gender

Male

Age

18 Years to No maximum

Germany, Portugal, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026